Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zeatin is a naturally occurring cytokinin, a class of plant hormones derived from adenine. It was first discovered in immature corn kernels from the genus Zea. Zeatin exists as two geometric isomers (cis and trans), with trans-zeatin being the more biologically active form. In plants, zeatin promotes cell division, stimulates growth of lateral buds, delays leaf senescence (aging), and can enhance resistance to certain pathogens. In vitro studies have shown that zeatin has gerontomodulatory and anti-aging effects on human skin fibroblasts by preserving their replicative lifespan without toxic effects at concentrations up to 200 μM[1][2][6]. Its primary mechanism of action is as an agonist for cytokinin receptors in plants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zeatin.